- Home
- PHGE vs HWH Comparison
PHGE vs HWH Comparison
Compare PHGE & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- HWH
- Stock Information
- Founded
- PHGE 2015
- HWH 2021
- Country
- PHGE Israel
- HWH United States
- Employees
- PHGE N/A
- HWH N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- HWH Other Pharmaceuticals
- Sector
- PHGE Health Care
- HWH Health Care
- Exchange
- PHGE Nasdaq
- HWH Nasdaq
- Market Cap
- PHGE 11.0M
- HWH 9.1M
- IPO Year
- PHGE N/A
- HWH N/A
- Fundamental
- Price
- PHGE $0.39
- HWH $1.39
- Analyst Decision
- PHGE Strong Buy
- HWH
- Analyst Count
- PHGE 1
- HWH 0
- Target Price
- PHGE $15.00
- HWH N/A
- AVG Volume (30 Days)
- PHGE 3.0M
- HWH 38.8K
- Earning Date
- PHGE 08-13-2025
- HWH 08-11-2025
- Dividend Yield
- PHGE N/A
- HWH N/A
- EPS Growth
- PHGE N/A
- HWH N/A
- EPS
- PHGE N/A
- HWH N/A
- Revenue
- PHGE N/A
- HWH $1,262,664.00
- Revenue This Year
- PHGE N/A
- HWH N/A
- Revenue Next Year
- PHGE N/A
- HWH N/A
- P/E Ratio
- PHGE N/A
- HWH N/A
- Revenue Growth
- PHGE N/A
- HWH 37.84
- 52 Week Low
- PHGE $0.34
- HWH $0.90
- 52 Week High
- PHGE $3.48
- HWH $7.20
- Technical
- Relative Strength Index (RSI)
- PHGE 37.11
- HWH 54.58
- Support Level
- PHGE $0.38
- HWH $1.29
- Resistance Level
- PHGE $0.77
- HWH $1.43
- Average True Range (ATR)
- PHGE 0.06
- HWH 0.09
- MACD
- PHGE -0.00
- HWH -0.00
- Stochastic Oscillator
- PHGE 6.52
- HWH 54.25
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.